{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:46:21Z","timestamp":1765079181561},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T00:00:00Z","timestamp":1286928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00109-010-0686-2","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T12:38:40Z","timestamp":1286973520000},"page":"65-74","source":"Crossref","is-referenced-by-count":16,"title":["ACE activity is modulated by the enzyme \u03b1-galactosidase A"],"prefix":"10.1007","volume":"89","author":[{"given":"Elice Carneiro","family":"Batista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Roberto","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce Elena","family":"Casarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Karaoglanovic","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson Lucas","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elton Dias","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robson Augusto","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clovis Ryuichi","family":"Nakaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ver\u00f4nica Munoz","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzana Macedo","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e2nia","family":"D\u2019Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kely","family":"de Picoly Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Bosco","family":"Pesquero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"issue":"21","key":"686_CR1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","volume":"276","author":"RO Brady","year":"1967","unstructured":"Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Lastes L (1967) Enzymatic defect in Fabry\u2019s disease Ceramidetrihexosidase deficiency. N Engl J Med 276(21):1163\u20131167","journal-title":"N Engl J Med"},{"key":"686_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/345309","volume":"72","author":"D Bloom","year":"2003","unstructured":"Bloom D, Speijer D, Linthosrt GE, Donker-Koopman WG, Strijland A, Aerts JMFG (2003) Recombinant enzyme therapy for Fabry disease: absence of editing of human \u03b1-galactosidase A mRNA. Am J Hum Genet 72:23\u201331","journal-title":"Am J Hum Genet"},{"key":"686_CR3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","volume":"146","author":"TR Clarke","year":"2007","unstructured":"Clarke TR (2007) Narrative review: Fabry disease. Ann Intern Med 146:425\u2013433","journal-title":"Ann Intern Med"},{"key":"686_CR4","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","volume":"284","author":"RO Brady","year":"2000","unstructured":"Brady RO, Schiffmann R (2000) Clinical features of and recent advances in therapy for Fabry disease. Jama 284:2771\u20132775","journal-title":"Jama"},{"key":"686_CR5","first-page":"3733","volume-title":"The metabolic and molecular basis of inherited disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Ioannou YA, Eng CM (2001) \u03b1-Galactosidase A deficiency: Fabry disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 3733\u20133774","edition":"8"},{"key":"686_CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00439-005-1300-5","volume":"117","author":"F Matsuzawa","year":"2005","unstructured":"Matsuzawa F, Aikawa SI, Doi H, Okumiya T, Sakuraba H (2005) Fabry disease: correlation between structural changes in \u03b1-galactosidase, and clinical and biochemical phenotypes. Hum Genet 117:317\u2013338","journal-title":"Hum Genet"},{"key":"686_CR7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH (2001) Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750\u2013760","journal-title":"J Med Genet"},{"issue":"46","key":"686_CR8","first-page":"51","volume":"60","author":"GM Altarescu","year":"2001","unstructured":"Altarescu GM, Goldfarb LG, Park KY, Kaneski C, Jeffries N, Litvalk S, Nagle JW, Schiffmann R (2001) Identification of fifteen novel mutations and genotype\u2013phenotype relationship in Fabry disease. Clin Genet 60(46):51","journal-title":"Clin Genet"},{"key":"686_CR9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RS Desnick","year":"2003","unstructured":"Desnick RS, Brady R, Barrenger J, Collins AJ, Germain DP, Goldman M, Grabowsiki G, Packman S, Wilcose WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338\u2013346","journal-title":"Ann Intern Med"},{"key":"686_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, Goldfarb L, Brady RO, Balow JE, Austin HA III et al (2002) Natural history of Fabry renal disease: influence of alfa-galactosidase A activity and genetic mutations on clinical course. Medicine 81:122\u2013138","journal-title":"Medicine"},{"issue":"2","key":"686_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1012447102358","volume":"24","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH (2001) Natural history of Fabry disease in affected males and obligate carrier females. J Inherit Metab Dis 24(2):13\u201314","journal-title":"J Inherit Metab Dis"},{"key":"686_CR12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","volume":"30","author":"AC Vedder","year":"2007","unstructured":"Vedder AC, Linthorst GE, van Breemen MJ, Groener JEM, Bemelman FJ, Strijland A, Mannens MMAM, Aerts JMFG, Hollak CEM (2007) The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels. J Inherit Metab Dis 30:68\u201378","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"686_CR13","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","volume":"105","author":"JM Aerts","year":"2008","unstructured":"Aerts JM, Groener JE, Kuiper S, Donker-Koopman WE, Strijland A, Ottenhoff R, Van Roomen C, Mirzaian M, Wijburg FA, Linthorst GE et al (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. PNAS 105(8):2812\u20132817","journal-title":"PNAS"},{"key":"686_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, Caplan L, Linthorst GE, Desnick RJ (2001) Safety and efficacy of recombinant human alfa-galactosidase A replacement therapy in Fabry\u2019s disease. N Engl J Med 345:9\u201316","journal-title":"N Engl J Med"},{"key":"686_CR15","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA III, Sabnis S, Moore DF, Weibel T, Balow JE, Brady RO (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285:2743\u20132749","journal-title":"JAMA"},{"key":"686_CR16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot KD, Holmes A, Miners AH (2001) Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769\u2013775","journal-title":"J Med Genet"},{"issue":"7","key":"686_CR17","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.1371\/journal.pone.0000598","volume":"2","author":"AC Vedder","year":"2007","unstructured":"Vedder AC, Linthorst GE, Houge G, Groener JEM, Ormel EE, Bouma BJ, Aerts JMFG, Hirth A, Hollak CEM (2007) Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2\u00a0mg\/kg. PLoS ONE 2(7):e598. doi: 10.1371\/journal.pone.0000598","journal-title":"PLoS ONE"},{"issue":"9","key":"686_CR18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng CM, Germain DP, DP BM, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K et al (2006) Fabry disease: guidelines for the evaluation and management of multiorgan system involvement. Genet Med 8(9):539\u2013548","journal-title":"Genet Med"},{"key":"686_CR19","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.87.6.1816","volume":"87","author":"KK Griedling","year":"1993","unstructured":"Griedling KK, Murphy TJ, Alexander RW (1993) Molecular biology of the renin-angiotensin system. Circulation 87:1816\u20131828","journal-title":"Circulation"},{"key":"686_CR20","first-page":"261","volume":"250","author":"DW Cushman","year":"1971","unstructured":"Cushman DW, Cheung HS (1971) Concentration of angiotensin converting enzyme in tissues of rat. BBA 250:261\u2013265","journal-title":"BBA"},{"key":"686_CR21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/1043-2760(90)90052-5","volume":"1","author":"FAO Mendelsohn","year":"1990","unstructured":"Mendelsohn FAO, Allen AM, Chai SY, McKinley MJ, Oldfield BJ, Paxinos G (1990) The brain angiotensin system: insights from mapping its components. Trends Endocrinol Metab 1:189\u2013197","journal-title":"Trends Endocrinol Metab"},{"key":"686_CR22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2362.2001.00839.x","volume":"31","author":"M Carluccio","year":"2001","unstructured":"Carluccio M, Soccio M, De Caterina R (2001) Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system. Eur J Clin Invest 31:476\u2013488","journal-title":"Eur J Clin Invest"},{"key":"686_CR23","doi-asserted-by":"crossref","first-page":"8519","DOI":"10.1021\/bi9928905","volume":"39","author":"MC Araujo","year":"2000","unstructured":"Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L, Carmona AK (2000) Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme. Biochemistry 39:8519\u20138525","journal-title":"Biochemistry"},{"issue":"10","key":"686_CR24","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/01.hjh.0000183523.66123.95","volume":"23","author":"FA Ronchi","year":"2005","unstructured":"Ronchi FA, Andrade MC, Carmona AK, Krieger JE, Casarini DE (2005) N-domain angiotensin-converting enzyme isoform expression in tissues of Wistar and spontaneously hypertensive rats. J Hypertens 23(10):1793\u20131794","journal-title":"J Hypertens"},{"key":"686_CR25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ab.2007.01.020","volume":"363","author":"RA Sabatini","year":"2007","unstructured":"Sabatini RA, Bersanetti PA, Farias SL, Juliano L, Juliano MA, Casarini DE, Carmona AK, Paiva ACM, Pesquero JB (2007) Determination of angiotensin I-converting enzyme activity in cells in culture using fluorescence resonance energy transfer peptides. Anal Biochem 363:255\u2013262","journal-title":"Anal Biochem"},{"key":"686_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"1","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 1:265\u2013275","journal-title":"J Biol Chem"},{"key":"686_CR27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-4-21","volume":"4","author":"B Hoffmann","year":"2009","unstructured":"Hoffmann B (2009) Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring. Orphanet J Rare Dis 4:21","journal-title":"Orphanet J Rare Dis"},{"key":"686_CR28","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","volume":"288","author":"JT Wright","year":"2002","unstructured":"Wright JT, Bakris G, Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG (2002) African American study of kidney disease and hypertension study group: effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK Trial. JAMA 288:2421\u20132431","journal-title":"JAMA"},{"key":"686_CR29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-136-8-200204160-00010","volume":"136","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi G, Ruggenenti P, Perico N (2002) Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136:604","journal-title":"Ann Intern Med"},{"key":"686_CR30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.7326\/0003-4819-141-12-200412210-00009","volume":"12","author":"AD Rule","year":"2004","unstructured":"Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG (2004) Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 12:929\u2013937","journal-title":"Ann Intern Med"},{"key":"686_CR31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(00)70054-0","volume":"35","author":"P Ruggenenti","year":"2000","unstructured":"Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G (2000) Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis 35:1155\u20131165","journal-title":"Am J Kidney Dis"},{"key":"686_CR32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.ajkd.2006.10.014","volume":"49","author":"PA Sarafidis","year":"2007","unstructured":"Sarafidis PA, Khosla N, Bakris GL (2007) Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis 49:12\u201326","journal-title":"Am J Kidney Dis"},{"key":"686_CR33","doi-asserted-by":"crossref","unstructured":"Warnock DG (2009) Optimizing treatment to reach therapeutic goals in Fabry disease. Clinical Therapeutics 31, Supplement A","DOI":"10.1016\/S0149-2918(09)00244-6"},{"key":"686_CR34","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1681\/ASN.2006121400","volume":"18","author":"H Tahir","year":"2007","unstructured":"Tahir H, Jackson LL, Warnock DG (2007) Antiproteinuric therapy and Fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta. J Am Soc Nephrol 18:2609\u20132617","journal-title":"J Am Soc Nephrol"},{"key":"686_CR35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10038-005-0342-9","volume":"51","author":"H Sakuraba","year":"2006","unstructured":"Sakuraba H, Murata-Ohsawa M, Kawashima I, Tajima Y, Kotani M, Ohshima T, Chiba Y, Takashiba M, Jigami Y, Fukushige T (2006) Comparison of the effects of agalsidase alfa and agalsidase beta on cultured human Fabry fibroblasts and Fabry mice. J Hum Genet 51:180\u2013188","journal-title":"J Hum Genet"},{"key":"686_CR36","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1681\/ASN.2006111263","volume":"18","author":"R Schiffmann","year":"2007","unstructured":"Schiffmann R, Askari H, Timmons M, Robinson C, Benko W, Brady RO, Ries M (2007) Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing. J Am Soc Nephrol 18:1576\u20131583","journal-title":"J Am Soc Nephrol"},{"key":"686_CR37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/glycob\/7.4.565","volume":"7","author":"B Baudin","year":"1997","unstructured":"Baudin B, Alves N, Pilon A, Beneteau-Burnat B, Giboudeau J (1997) Structural and biological roles of glycosylation in pulmonary angiotensin I-converting enzyme. Glycobiology 7:565\u2013570","journal-title":"Glycobiology"},{"key":"686_CR38","first-page":"H744","volume":"271","author":"R Ramchandran","year":"1996","unstructured":"Ramchandran R, Kasturi S, Douglas JG, Sen I (1996) Metalloprotease-mediated cleavage secretion of pulmonary ACE by vascular endothelial and kidney epithelial cells. Am J Physiol 271:H744\u2013H751","journal-title":"Am J Physiol"},{"key":"686_CR39","doi-asserted-by":"crossref","first-page":"10511","DOI":"10.1074\/jbc.274.15.10511","volume":"274","author":"R Sadhukhan","year":"1999","unstructured":"Sadhukhan R, Santhamma KR, Reddy P, Peschon JJ, Black RA, Sen I (1999) Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alphaconverting enzyme-deficient mice. J Biol Chem 274:10511\u201310516","journal-title":"J Biol Chem"},{"key":"686_CR40","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1073\/pnas.85.24.9386","volume":"85","author":"F Soubrier","year":"1988","unstructured":"Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P (1988) Two putative active centers in human angiotensin I converting enzyme revealed by molecular cloning. Proc Natl Acad Sci 85:9386\u20139390","journal-title":"Proc Natl Acad Sci"},{"key":"686_CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1006\/bbrc.1993.2278","volume":"196","author":"JE Ripka","year":"1993","unstructured":"Ripka JE, Ryan JW, Valido FA, Chung AYK, Peterson CM, Urry RL (1993) N-glycosylation of forms of angiotensin converting enzyme from four mammalian species. Biochem Biophys Res Commun 196:503\u2013508","journal-title":"Biochem Biophys Res Commun"},{"key":"686_CR42","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1074\/jbc.272.6.3511","volume":"272","author":"XC Yu","year":"1997","unstructured":"Yu XC, Sturrock ED, Wu Zh, Biemann K, Ehlers MRW, Riordan JF (1997) Identification of N-linked glycosylation sites in human testis angiotensin-converting enzyme and expression of an active deglycosylated form. J Biol Chem 272:3511\u20133519","journal-title":"J Biol Chem"},{"key":"686_CR43","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1099-1352(200011\/12)13:6<360::AID-JMR508>3.0.CO;2-K","volume":"13","author":"OA Kost","year":"2000","unstructured":"Kost OA, Bovin NV, Chemodanova EE, Nasonov VV, Orth TA (2000) New feature of angiotensin-converting enzyme: carbohydrate-recognizing domain. J Mol Recognit 13:360\u2013369","journal-title":"J Mol Recognit"},{"issue":"1","key":"686_CR44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0049-3848(95)00219-7","volume":"81","author":"HR Gralnick","year":"1996","unstructured":"Gralnick HR, Kramer WS, McKeown LP, Garfinkel L, Pinot A, Williams SB, Krutzsch H (1996) Platelet adhesion at high shear rates: the roles of von Willebrand factor\/GPIb and the beta 1 integrin alpha 2 beta 1. Thromb Res 81(1):113\u2013119","journal-title":"Thromb Res"},{"key":"686_CR45","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0005-2744(78)90177-8","volume":"524","author":"JM Conroy","year":"1978","unstructured":"Conroy JM, Hartley JM, Soffer RL (1978) Canine pulmonary angiotensin-converting enzyme: Physicochemical, catalytic and immunological properties. Biochim Biophys Acta 524:403\u2013412","journal-title":"Biochim Biophys Acta"},{"key":"686_CR46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(98)00767-4","volume":"431","author":"T Orth","year":"1998","unstructured":"Orth T, Voronov S, Binevski P, Saenger W, Kost OA (1998) Glycosylation of bovine pulmonary angiotensin-converting enzyme modulates its catalytic properties. FEBS Lett 431:255\u2013258","journal-title":"FEBS Lett"},{"key":"686_CR47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0076-6879(95)48020-X","volume":"248","author":"P Corvol","year":"1995","unstructured":"Corvol P, Williams TA, Soubrier F (1995) Dipeptidyl dipeptidase: angiotensin-converting enzyme. Meth Enzymol 248:283\u2013305","journal-title":"Meth Enzymol"},{"key":"686_CR48","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1021\/bi00439a002","volume":"28","author":"MRW Ehlers","year":"1989","unstructured":"Ehlers MRW, Riordan JF (1989) Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 28:5318\u20135322","journal-title":"Biochemistry"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-010-0686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-010-0686-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-010-0686-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T19:48:14Z","timestamp":1636660094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-010-0686-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,13]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["686"],"URL":"https:\/\/doi.org\/10.1007\/s00109-010-0686-2","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,13]]}}}